Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Change in Account Payables (2019 - 2025)

Keros Therapeutics filings provide 7 years of Change in Account Payables readings, the most recent being -$697000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 137.88% to -$697000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.0 million, a 1105.22% decrease, with the full-year FY2025 number at -$3.0 million, down 1105.22% from a year prior.
  • Change in Account Payables hit -$697000.0 in Q4 2025 for Keros Therapeutics, up from -$3.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.7 million in Q2 2022 to a low of -$5.0 million in Q3 2022.
  • Median Change in Account Payables over the past 5 years was -$79500.0 (2023), compared with a mean of -$27950.0.
  • Biggest five-year swings in Change in Account Payables: tumbled 774.73% in 2024 and later soared 8678.26% in 2025.
  • Keros Therapeutics' Change in Account Payables stood at $823000.0 in 2021, then fell by 27.7% to $595000.0 in 2022, then soared by 75.46% to $1.0 million in 2023, then crashed by 128.07% to -$293000.0 in 2024, then plummeted by 137.88% to -$697000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$697000.0 (Q4 2025), -$3.0 million (Q3 2025), and -$1.4 million (Q2 2025) per Business Quant data.